JENNIFER DYOTT: Open Payments
NPI 1508294745 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 7 payments from 6 companies in 2025. Trend: 2023 $100 · 2024 $272 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $58 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| Exeltis, USA Inc. | 1 | $27 |
| Sage Therapeutics, LLC | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $20 |
Products named: NEXPLANON, KEYTRUDA, Veozah, SLYND, ZURZUVAE, Phexxi.
Industry payments across MD — which companies pay providers there.
